SCHEMBL4422487

SCHEMBL4422487

COc1ccc(CC(=O)c2cc(C)cc(OC)c2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.56
HTT P42858 2/20 0.56
LMNA P02545 1/20 0.56
KMT2A Q03164 2/20 0.51
RAB9A P51151 2/20 0.51
MEN1 O00255 1/20 0.51
ALDH1A1 P00352 1/20 0.51
CYP3A4 P08684 1/20 0.51
HPGD P15428 1/20 0.51
ATM Q13315 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
USP2 O75604 1/20 0.50
TP53 P04637 1/20 0.50
L3MBTL1 Q9Y468 2/20 0.49
HSP90AA1 P07900 1/20 0.49
POLB P06746 1/20 0.49
TDP1 Q9NUW8 1/20 0.47
MAPT P10636 1/20 0.47
TSPO P30536 1/20 0.47
NFKB1 P19838 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL392612 0.90 NPC1 (0.62) NPC1HTTLMNAKMT2ARAB9A
SCHEMBL16162272 0.83 NPC1 (0.55) NPC1HTTLMNAKMT2ARAB9A
SCHEMBL3097303 0.82 NPC1 (0.65) NPC1HTTLMNAKMT2ARAB9A
SCHEMBL3099733 0.82 NPC1 (0.65) NPC1HTTLMNAKMT2ARAB9A
SCHEMBL457954 0.81 NPC1 (0.73) NPC1HTTLMNAKMT2ARAB9A
SCHEMBL988139 0.81 NPC1 (0.46) NPC1HTTLMNAKMT2ARAB9A
SCHEMBL12679986 0.80 NPC1 (0.43) NPC1HTTLMNARAB9AALDH1A1
SCHEMBL27572327 0.79 ALDH1A1 (0.63) NPC1HTTLMNAKMT2ARAB9A
SCHEMBL394844 0.79 POLB (0.58) NPC1HTTLMNAKMT2ARAB9A
SCHEMBL12637609 0.79 NPC1 (0.65) NPC1HTTLMNAKMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090326018-A1 2-Phenyl indene derivatives useful as estrogen receptor ligands KARO BIO AB (SE) 2009-12-31 US disclosed
US-20090326018-A1 2-Phenyl indene derivatives useful as estrogen receptor ligands KARO BIO AB (SE) 2009-12-31 US disclosed
US-20090326018-A1 2-Phenyl indene derivatives useful as estrogen receptor ligands KARO BIO AB (SE) 2009-12-31 US disclosed
EP-2074102-A1 2-PHENYL INDENE DERIVATIVES USEFUL AS ESTROGEN RECEPTOR LIGANDS KARO BIO AB (SE) 2009-07-01 EP disclosed
WO-2008043567-A1 2-PHENYL INDENE DERIVATIVES USEFUL AS ESTROGEN RECEPTOR LIGANDS KARO BIO AB (SE) 2008-04-17 WO disclosed
WO-2008043567-A1 2-PHENYL INDENE DERIVATIVES USEFUL AS ESTROGEN RECEPTOR LIGANDS KARO BIO AB (SE) 2008-04-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090326018-A1 2-Phenyl indene derivatives useful as estrogen receptor ligands ESR1, GPER1, ESR2 NPC1 651/4885HTT 4114/4885LMNA 2411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.